Daiichi Sankyo Company, Limited (Japanese: 第一三共株式会社, Hepburn: Daiichi Sankyō Kabushiki-gaisha) is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 981.8 billion in revenue in 2019. The company owns the American biotechnology company Plexxikon, American pharmaceutical company American Regent, German biotechnology company U3 Pharma, and recently sold Ranbaxy Laboratories in India. Daiichi Sankyo Co., Ltd. is the producer of Benicar (Olmesartan), an angiotensin II receptor antagonist and top selling drug in the U.S. Global sales of Olmesartan in 2013 were 300.2 billion yen. More information...
According to PR-model, daiichisankyo.co.jp is ranked 115,128th in multilingual Wikipedia, in particular this website is ranked 7,850th in Japanese Wikipedia.
The website is placed before roland.co.jp and after nhkworldpremium.com in the BestRef global ranking of the most important sources of Wikipedia.
